AIRS
Airsculpt Technologies IncNASDAQHEALTHCAREMEDICAL CARE FACILITIES
Key Statistics
Market Cap
$234.21M
P/E Ratio
—
EPS
$-0.19
Beta
2.27
52W High
$12.00
52W Low
$1.51
50-Day MA
$2.47
200-Day MA
$4.64
Dividend Yield
—
Profit Margin
-7.69%
Forward P/E
—
PEG Ratio
—
About Airsculpt Technologies Inc
Airsculpt Technologies Inc (AIRS) is a leader in the aesthetic medical technology field, recognized for its proprietary AirSculpt® procedure, which offers minimally invasive body contouring solutions while emphasizing patient safety and comfort. The company boasts a growing network of licensed practitioners and a strong focus on technological innovation, positioning itself advantageously in the expanding market for non-invasive cosmetic treatments. By responding to the rising global demand for aesthetic procedures, Airsculpt aims to enhance its market share and diversify its service offerings, thereby fostering both immediate growth and sustainable long-term value for investors.
Fundamentals
| Revenue (TTM) | $151.82M |
| Gross Profit (TTM) | $100.13M |
| EBITDA | $7.95M |
| Operating Margin | -4.56% |
| Return on Equity | -14.10% |
| Return on Assets | -1.51% |
| Revenue/Share (TTM) | $2.51 |
| Book Value | $1.36 |
| Price-to-Book | 2.67 |
| Price-to-Sales (TTM) | 1.54 |
| EV/Revenue | 2.038 |
| EV/EBITDA | 253.34 |
| Quarterly Earnings Growth (YoY) | 200.00% |
| Quarterly Revenue Growth (YoY) | -14.60% |
| Shares Outstanding | $70.55M |
| Float | $9.96M |
| % Insiders | 42.64% |
| % Institutions | 67.75% |
Analyst Ratings
Consensus ($3.00 target)
2
HoldData last updated: 5/2/2026